All Stories

  1. Implementing the EU HTA Regulation in Italy: a multi-stakeholder perspective from the Mogliano Veneto Working Group
  2. Budget impact of MhZT for intermittent catheterization in people with multiple sclerosis or spinal cord injury in Italy
  3. Cooperation among stakeholders for the sustainability of the new pharmaceutical paradigm in Italy
  4. Erratum in: Economic evaluation of distribution modalities for ostomy and incontinence medical devices within the Italian healthcare context
  5. Economic evaluation of distribution modalities for ostomy and incontinence medical devices within the italian healthcare context
  6. Clinical and economic burden of urinary tract infections in patients with spinal cord injury and multiple sclerosis in Italy
  7. Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum
  8. Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context
  9. Towards a Green Health Technology Assessment: embedding Life Cycle Assessment for sustainable choices
  10. Functional coronary assessment in angina with intermediate coronary stenosis: the #FullPhysiology approach
  11. Policy predictive model for better management of chronic obstructive pulmonary disease: economic-organisational implications in the Italian healthcare system
  12. Cost effectiveness of difelikefalin for the treatment of patients with chronic kidney disease-associated pruritus undergoing hemodialysis in Italy
  13. The economic and social burden of congenital thrombotic thrombocytopenic purpura (cTTP) in Italy
  14. The socio-environmental determinants of diabetes and their consequences
  15. Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
  16. Feasibility of a Stop Smoking Program for Healthcare Workers in an Italian Hospital: Econometric Analysis in a Total Worker Health® Approach
  17. The added value of applying a disinvestment approach to the process of health technology assessment in Italy
  18. Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model
  19. Return on Investment (ROI) and Development of a Workplace Disability Management Program in a Hospital—A Pilot Evaluation Study
  20. A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer
  21. Estimating the fiscal impact of three vaccination strategies in Italy
  22. NutriCatt protocol in the Enhanced Recovery After Surgery (ERAS) program for colorectal surgery: The nutritional support improves clinical and cost-effectiveness outcomes
  23. PD43 Value-Based Procedure For Updating The Italian Health Benefit Package
  24. Evolution of the Healthcare Expenditure in Italy and Effects of Fingolimod Increased Prescribing in Second Line Treatment of Relapsing-Remitting Multiple Sclerosis
  25. Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature